Ownership history in Bayesian Capital Management, LP · 7 quarters on record
This page tracks every 13F SEC filing in which Bayesian Capital Management, LP reported a position in MADRIGAL PHARMACEUTICALS INC (MDGL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 491 | -889 | -64.4% | 0.05% | $225K | $458.66 |
| 2025 Q2 | REDUCED | 1,380 | -2,193 | -61.4% | 0.07% | $418K | $302.64 |
| 2024 Q4 | ADDED | 3,573 | +2,071 | +137.9% | 0.13% | $1.1M | $308.57 |
| 2024 Q3 | REDUCED | 1,502 | -1,907 | -55.9% | 0.04% | $319K | $212.22 |
| 2024 Q2 | REDUCED | 3,409 | -2,451 | -41.8% | 0.11% | $955K | $280.16 |
| 2023 Q2 | ADDED | 5,860 | +3,510 | +149.4% | 0.15% | $1.4M | $231.00 |
| 2022 Q4 | INITIATED | 2,350 | — | — | 0.10% | $682K | — |
As of 2025 Q4 — sorted by position size